Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

22.7K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
22.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new era for myotonic dystrophy: Improved delivery of a DMPK-targeted oligonucleotide modulates muscle transcriptomes and function.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation.

Nucleic acids research·2026
Same author

Enhanced antisense oligonucleotide delivery reveals that transcript turnover impacts apparent splicing rescue in myotonic dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Myonuclear Domain-Associated and Central Nucleation-Dependent Spatial Restriction of Dystrophin Protein Expression.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation.

bioRxiv : the preprint server for biology·2026
Same author

Metformin improves RAN protein pathology, alternative splicing, and behavioral phenotypes in SCA8 mice.

Life science alliance·2026
Same journal

The Solomon Technique and Extreme Preterm Birth after Laser Surgery for Twin-Twin Transfusion Syndrome.

Fetal diagnosis and therapy·2026
Same journal

Prenatal and molecular characteristics of 23 cases with Silver-Russell syndrome.

Fetal diagnosis and therapy·2026
Same journal

Consequences of selective fetal growth restriction in perinatal outcomes after fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome, based on single or dual survival.

Fetal diagnosis and therapy·2026
Same journal

Turning image labelling into knowledge: insights from fetal Left ventricular outflow tract annotation.

Fetal diagnosis and therapy·2026
Same journal

First-trimester growth rate in relation to selective fetal growth restriction in monochorionic twins.

Fetal diagnosis and therapy·2026
Same journal

Erratum.

Fetal diagnosis and therapy·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K

Identifying Robertsonian Translocation Carriers by Microarray-Based DNA Analysis.

Stephanie Huang1, Kara Juneau, Patrick E Bogard

  • 1Ariosa Diagnostics Inc., San Jose, Calif., USA.

Fetal Diagnosis and Therapy
|March 2, 2016
PubMed
Summary
This summary is machine-generated.

A new noninvasive prenatal test improves identification of Robertsonian translocation carriers. This method accurately assesses fetal trisomy and maternal translocation status, providing crucial reproductive information.

More Related Videos

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

20.7K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K

Related Experiment Videos

Last Updated: Mar 24, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

20.7K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K

Area of Science:

  • Genetics
  • Reproductive Biology
  • Molecular Diagnostics

Background:

  • Robertsonian translocations are the most common chromosomal abnormalities.
  • These translocations can lead to significant reproductive challenges and fetal aneuploidies.
  • Current diagnostic methods may be invasive or lack comprehensive carrier identification.

Purpose of the Study:

  • To develop and validate a noninvasive prenatal testing (NIPT) improvement for identifying Robertsonian translocation carriers.
  • To enhance NIPT by incorporating specific assays for maternal Robertsonian translocation status.
  • To provide accurate risk assessment for fetal trisomy in the context of maternal Robertsonian translocations.

Main Methods:

  • Utilized Digital Analysis of Selected Regions (DANSR™) assays targeting acrocentric chromosome p arms.
  • Developed the Fetal-Fraction Optimized Risk of Trisomy Evaluation (FORTE™) algorithm to analyze cell-free DNA fractions.
  • Analyzed blood samples from 191 subjects, including carriers and non-carriers, using DNA microarrays.

Main Results:

  • The FORTE™ algorithm achieved 100% accuracy in classifying both fetal trisomy and maternal Robertsonian translocation status across all 191 samples.
  • Identified 16 samples with a high Robertsonian risk score (>99%) and 175 samples with a low risk score (<0.01%).
  • Demonstrated the efficacy of DANSR™ assays and the FORTE™ algorithm in a clinical setting.

Conclusions:

  • The developed noninvasive method effectively identifies Robertsonian translocation carriers.
  • This NIPT improvement offers valuable information for women regarding reproductive risks.
  • Accurate identification of maternal Robertsonian translocation status can guide prenatal counseling and management.